Biotech SF: Arch Venture Partners

Showing posts with label Arch Venture Partners. Show all posts

Thursday, June 30, 2011

Bay Area transplant Sorbent Therapeutics closes $53M Series B financing

Sorbent Therapeutics Inc. closed a $53 million Series B financing round led by new investor Novartis Venture Funds.
A Bay Area transplant from Chicago, the three-employee Sunnyvale company will use the money to complete a mid-stage program for its lead congestive heart failure drug and slowly add a few employees, CEO Detlef Albrecht said.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.